These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 25864092

  • 1. Movement disorders and brain iron overload in a new subtype of aceruloplasminemia.
    Melgari JM, Marano M, Quattrocchi CC, Piperno A, Arosio C, Frontali M, Nuovo S, Siotto M, Salomone G, Altavilla R, di Biase L, Scrascia F, Squitti R, Vernieri F.
    Parkinsonism Relat Disord; 2015 Jun; 21(6):658-60. PubMed ID: 25864092
    [No Abstract] [Full Text] [Related]

  • 2. Central nervous system involvement in a rare genetic iron overload disorder.
    Bethlehem C, van Harten B, Hoogendoorn M.
    Neth J Med; 2010 Oct; 68(10):316-8. PubMed ID: 21071777
    [Abstract] [Full Text] [Related]

  • 3. Does aceruloplasminemia modulate iron phenotype in thalassemia intermedia?
    Pelucchi S, Pelloni I, Arosio C, Mariani R, Piperno A.
    Blood Cells Mol Dis; 2016 Mar; 57():112-4. PubMed ID: 26777753
    [No Abstract] [Full Text] [Related]

  • 4. Novel ceruloplasmin mutation causing aceruloplasminemia with hepatic iron overload and diabetes without neurological symptoms.
    Rusticeanu M, Zimmer V, Schleithoff L, Wonney K, Viera J, Zimmer A, Hübschen U, Bohle RM, Grünhage F, Lammert F.
    Clin Genet; 2014 Mar; 85(3):300-1. PubMed ID: 23557349
    [No Abstract] [Full Text] [Related]

  • 5. Aceruloplasminemia With Positive Ceruloplasm Gene Mutation.
    Kang HG, Kim M, Lee SC.
    JAMA Ophthalmol; 2016 Jul 14; 134(7):e160816. PubMed ID: 27416276
    [No Abstract] [Full Text] [Related]

  • 6. Aceruloplasminemia and putaminal cavitation.
    Riboldi GM, Anstett K, Jain R, Lau H, Swope D.
    Parkinsonism Relat Disord; 2018 Jun 14; 51():121-123. PubMed ID: 29534945
    [No Abstract] [Full Text] [Related]

  • 7. Aceruloplasminemia: an update.
    Kono S.
    Int Rev Neurobiol; 2013 Jun 14; 110():125-51. PubMed ID: 24209437
    [Abstract] [Full Text] [Related]

  • 8. Extending the aceruloplasminemia phenotype: NBIA on imaging and acanthocytosis, yet only minor neurological findings.
    Kassubek R, Uttner I, Schönfeldt-Lecuona C, Kassubek J, Connemann BJ.
    J Neurol Sci; 2017 May 15; 376():151-152. PubMed ID: 28431603
    [No Abstract] [Full Text] [Related]

  • 9. [Aceruloplasminemia, a rare condition not to be overlooked].
    Lobbes H, Reynaud Q, Mainbourg S, Lega JC, Durieu I, Durupt S.
    Rev Med Interne; 2020 Nov 15; 41(11):769-775. PubMed ID: 32682623
    [Abstract] [Full Text] [Related]

  • 10. Treatment of symptomatic heterozygous aceruloplasminemia with oral zinc sulphate.
    Kuhn J, Bewermeyer H, Miyajima H, Takahashi Y, Kuhn KF, Hoogenraad TU.
    Brain Dev; 2007 Aug 15; 29(7):450-3. PubMed ID: 17307325
    [Abstract] [Full Text] [Related]

  • 11. Aceruloplasminemia in a Turkish adolescent with a novel mutation of ceruloplasmin gene: the first diagnosed case from Turkey.
    Meral Gunes A, Sezgin Evim M, Baytan B, Iwata A, Hida A, Avci R.
    J Pediatr Hematol Oncol; 2014 Oct 15; 36(7):e423-5. PubMed ID: 25247888
    [Abstract] [Full Text] [Related]

  • 12. Seizures in Hereditary Aceruloplasminemia.
    Marano M, Bove F, Ricci L, Rohani M, Di Lazzaro V, Assenza G, Fasano A.
    Can J Neurol Sci; 2021 Jan 15; 48(1):144-147. PubMed ID: 32741407
    [No Abstract] [Full Text] [Related]

  • 13. Aceruloplasminemia.
    Kono S.
    Curr Drug Targets; 2012 Aug 15; 13(9):1190-9. PubMed ID: 22515740
    [Abstract] [Full Text] [Related]

  • 14. Clinical relevance of heterozygosis for aceruloplasminemia.
    Borges MD, de Albuquerque DM, Lanaro C, Costa FF, Fertrin KY.
    Am J Med Genet B Neuropsychiatr Genet; 2019 Jun 15; 180(4):266-271. PubMed ID: 30901137
    [Abstract] [Full Text] [Related]

  • 15. Ceruloplasmin deficiency does not induce macrophagic iron overload: lessons from a new rat model of hereditary aceruloplasminemia.
    Kenawi M, Rouger E, Island ML, Leroyer P, Robin F, Rémy S, Tesson L, Anegon I, Nay K, Derbré F, Brissot P, Ropert M, Cavey T, Loréal O.
    FASEB J; 2019 Dec 15; 33(12):13492-13502. PubMed ID: 31560858
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hepatic but not brain iron is rapidly chelated by deferasirox in aceruloplasminemia due to a novel gene mutation.
    Finkenstedt A, Wolf E, Höfner E, Gasser BI, Bösch S, Bakry R, Creus M, Kremser C, Schocke M, Theurl M, Moser P, Schranz M, Bonn G, Poewe W, Vogel W, Janecke AR, Zoller H.
    J Hepatol; 2010 Dec 15; 53(6):1101-7. PubMed ID: 20801540
    [Abstract] [Full Text] [Related]

  • 18. Aceruloplasminemia: Unique Clinical and MRI Findings in a Patient with a Novel Frameshift Mutation.
    Colucci F, Barca S, Cilia R, De Franco V, Elia AE, Golfrè Andreasi N, Romito L, Telese R, Braccia A, Leta V, Grisoli M, Panteghini C, Garavaglia B, Devigili G, Eleopra R.
    Mov Disord Clin Pract; 2024 Aug 15; 11 Suppl 2(Suppl 2):S14-S16. PubMed ID: 38400595
    [No Abstract] [Full Text] [Related]

  • 19. New insights in the neurological phenotype of aceruloplasminemia in Caucasian patients.
    Vroegindeweij LHP, Langendonk JG, Langeveld M, Hoogendoorn M, Kievit AJA, Di Raimondo D, Wilson JHP, Boon AJW.
    Parkinsonism Relat Disord; 2017 Mar 15; 36():33-40. PubMed ID: 28012953
    [Abstract] [Full Text] [Related]

  • 20. Genetic and Clinical Heterogeneity in Thirteen New Cases with Aceruloplasminemia. Atypical Anemia as a Clue for an Early Diagnosis.
    Vila Cuenca M, Marchi G, Barqué A, Esteban-Jurado C, Marchetto A, Giorgetti A, Chelban V, Houlden H, Wood NW, Piubelli C, Dorigatti Borges M, Martins de Albuquerque D, Yotsumoto Fertrin K, Jové-Buxeda E, Sanchez-Delgado J, Baena-Díez N, Burnyte B, Utkus A, Busti F, Kaubrys G, Suku E, Kowalczyk K, Karaszewski B, Porter JB, Pollard S, Eleftheriou P, Bignell P, Girelli D, Sanchez M.
    Int J Mol Sci; 2020 Mar 30; 21(7):. PubMed ID: 32235485
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.